A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation

Clinical trial NCT04856982 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04856982
Sponsor: Biogen
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation

Start date: 2021-05-17
Primary completion: 2027-08-07
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.